HALO logo
halo search icon
Ascendis Pharma A/S
Ascendis Pharma A/S
ASND · NAS

Ascendis Pharma A/S

US$241.34

Price Arrow3.36 (1.41%)
20/05/2026 04:00:00 PM
All-ConsensusEngulfing BearishEngulfing Bearish (Realtime)HALO AllHALO Capital EfficiencyHALO Earnings MomentumHALO GARPHALO Growth+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Ascendis Pharma A/S Overview

ASND Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About ASND

icon

Telephone

45.70.22.22.44

icon

Address

Tuborg Boulevard 12, Hellerup, Capital Region 2900

Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

ASND Price Chart

Key Stats

Market Cap

US$14.84B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 153.49 - 250.74

Trade Value (12mth)

US$30,268,427.00

1 week

-1.05%

1 month

-0.96%

YTD

11.58%

1 year

50.52%

All time high

250.74

Key Fundamentals

EPS 3 yr Growth

-63.80%

EBITDA Margin

-16.50%

Operating Cashflow

€54m

Free Cash Flow Return

23.00%

ROIC

-97.10%

Interest Coverage

-1.50

Quick Ratio

0.80

Other Data

Shares Outstanding (Fully Diluted)

65m

HALO Sector

Healthcare

Next Company Report Date

17-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

ASND Announcements

Latest Announcements

DateAnnouncements
14 May 26
07 May 26
07 May 26
07 May 26
07 May 26

ASND Fundamentals

Per Share Records

Historical data

Forecast data

EUR2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
locklocklocklock-8.55-6.53-3.76locklocklock
EPS (Fully Diluted)
locklocklocklock-8.55-6.53-3.76locklocklock
Growth
%locklocklocklock17.823.642.4locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Ascendis Pharma A/S (ASND:NAS)?
Halo FAQ
The current share price of Ascendis Pharma A/S (ASND:NAS) is USD$241.34.
What is the 52-week high share price for Ascendis Pharma A/S (ASND:NAS)?
Halo FAQ
The 52-week high share price for Ascendis Pharma A/S (ASND:NAS) is USD$250.74.
What is the 52-week low share price for Ascendis Pharma A/S (ASND:NAS)?
Halo FAQ
The 52-week low share price for Ascendis Pharma A/S (ASND:NAS) is USD$153.49.
What is the dividend yield for Ascendis Pharma A/S (ASND:NAS)?
Halo FAQ
Ascendis Pharma A/S (ASND:NAS) does not pay a dividend.
What was Ascendis Pharma A/S (ASND:NAS) last dividend payment?
Halo FAQ
Ascendis Pharma A/S (ASND:NAS) does not pay a dividend.
What is the franking level for Ascendis Pharma A/S (ASND:NAS)?
Halo FAQ
Ascendis Pharma A/S (ASND:NAS) has a franking level of 0.00%.
In which sector is Ascendis Pharma A/S (ASND:NAS) classified?
Halo FAQ
Ascendis Pharma A/S (ASND:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.